Addressing Performance, Scalability, and Regulatory Challenges to Accelerate Cell Therapy Manufacturing.

Detalles Bibliográficos
Publicado en:BioPharm International Vol. 37; no. 7; pp. 14 - 18
Autores principales: CASHEN, PAUL, DECKERS, SUSANNE, LADI, RUKMINI
Formato: pictorial tables/charts Journal Article
Publicado: MJH Life Sciences Jul/Aug2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179074687&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179074687
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Jul/Aug2024
      vid: 37
      iid: 7
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        179074687
        179074687
        179074687
        179074687
      ppf: 14
      ppct: 4
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Addressing Performance, Scalability, and Regulatory Challenges to Accelerate Cell Therapy Manufacturing.
      aug:
        au:
          CASHEN, PAUL
          DECKERS, SUSANNE
          LADI, RUKMINI
      sug:
        subj:
          Cell Therapy
          Gene Therapy
          Immunotherapy
          Receptors, Cell Surface
          Consumer Product Safety
          United States Food and Drug Administration
          Marketing
          Product Development
          Costs and Cost Analysis
          Government Regulations
      pubtype: Trade Publication
      doctype:
        pictorial
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N